有机锡4-(4-吡啶基甲基硫代)苯甲酸酯的合成、结构与生物活性研究(英文)

通过4-(4-吡啶基甲基硫代)苯甲酸与三苯基氧化锡以及三环己基氢氧化锡反应,合成了三苯基锡4-(4-吡啶基甲基硫代)苯甲酸酯(1)及三环己基锡4-(4-吡啶基甲基硫代)苯甲酸酯(2)。它们的结构通过红外,核磁以及X-射线单晶衍射分析得到确证。化合物1表现为一维链状结构,而化合物2通过分子间的O-H…O和O-H…N氢键形成二维网状结构。生物活性测试表明,这2个化合物具有较高的抗肿瘤活性。     

有机锡4-(4-吡啶基甲基硫代)苯甲酸酯的合成、结构与生物活性研究

通过4-（4-吡啶基甲基硫代）苯甲酸与三苯基氧化锡以及三环己基氢氧化锡反应,合成了三苯基锡4-（4-吡啶基甲基硫代）苯甲酸酯（1）及三环己基锡4-（4-吡啶基甲基硫代）苯甲酸酯（2）。它们的结构通过红外,核磁以及X-射线单晶衍射分析得到确证。化合物1表现为一维链状结构,而化合物2通过分子间的O-H…O和O-H…N氢键形成二维网状结构。生物活性测试表明,这2个化合物具有较高的抗肿瘤活性。     

有机锡2-[(1,2,4-三唑-1-基)甲基硫代]苯甲酸酯的合成与生物活性

通过硫代水杨酸与(1-氯甲基)-1,2,4-三唑盐酸盐在碱性条件下的反应, 合成了2-[(1,2,4-三唑-1-基)甲基硫代]苯甲酸. 利用该酸与(R₃Sn)₂O(R=Et, n-Bu, Ph), Cy₃SnOH(Cy为环己基)或Et₂SnO反应, 得到了5个有机锡羧酸酯. 用X射线单晶衍射测定了三正丁基锡2-[(1,2,4-三唑-1-基)甲基硫代]苯甲酸酯的晶体结构. 在该化合物中, 锡为五配位的三角双锥结构. 该化合物通过三唑四位氮原子与锡配位, 形成一维链状配位高分子. 初步的生物活性测试结果表明, 所有的有机锡化合物都表现出了明显的抗真菌活性.     

(Z)-1-[2-(三苯基锡基)乙烯基]-1-茚满醇及其酯和卤代物的合成与表征

在氮气保护下,1-乙炔茚满醇与三苯基氢化锡进行游离基加成反应,获得加成物(Z)-1-[2-(三苯基锡基)乙烯基]-1-茚满醇(1);将加成物(1)与苯酐反应,得到新型邻苯二甲酸单酯有机锡衍生物(2);衍生物(2)分别与二丁基氧化锡和三苯基氧化锡进行脱水反应,分别获得两个新型邻苯二甲酸酯的有机锡衍生物(3)和(4).将加成物(1)与卤素反应后,与锡原子直接相连的苯基被取代,得到一卤代和二卤代物(5～10).通过元素分析、¹HNMR和IR等手段对化合物1～10进行了结构表征,确定了该类邻苯二甲酸单酯和邻苯二甲酸酯的有机锡衍生物的结构.并测定了加成物(1)和一溴代物(6)的晶体结构,在加成物(1)中,由于分子内存在较弱的O→Sn[0.2778(8)nm]配位作用,锡原子呈扭曲三角双锥构型.在一溴代物(6)分子中,存在分子内O→Sn[0.2364(2)nm]配位键,锡原子呈扭曲的三角双锥构型.该系列化合物分子内的O→Sn配位能力和Lewis酸性强弱的顺序为:二卤化物>一卤化物>加成物;氯代物>溴代物>碘代物>加成物.     

三苯基锡硫代苯甲酸酯的合成、性质和晶体结构

用三苯基氯化锡与硫代苯甲酸在三乙胺存在下反应，合成了三苯基锡硫代苯甲 酸酯，并进行了红外光谱及核磁共振氢谱表征。X射线单晶衍射表明，化合物属正 交晶系，空间群P2_12_12_1，晶胞参数：a = 0.8306(3) nm, b = 1.6906(5) nm, c = 3.1459(10)) nm, V = 4.417(2) nm~3, Z = 8, D_c = 1.465 g/cm~3, R_1 = 0.0472, wR_2 = 0.1012。该化合物的晶体是由孤立的分子所组成，四配位的锡 原子呈畸变的四面体构型，配体羧基上的氧原子和锡原子之间存在弱的配位作用。     

1—羟基—2（1H）—吡啶硫酮及其甲基衍生物与Cr（Ⅲ）配合物的合成和性质

Edrissi认为Cr(Ⅲ)与1-羟基-2(1H)-吡啶硫酮(HPT)的甲基衍生物不能给出任何反应,并且将与HPT的配合物注明为绿色溶液。本文在过去工作的基础上合成了S-(1-氧化-2-吡啶基)硫代苯甲酸酯(PTB)和3-CH_3-PTB;并合成了3个铬配合物。通过元素分析,紫外-可见,红外光谱,摩尔电导和TG-DTA-DTG作了表征。探讨了形成机理并研究了抑菌活性。     

3-亚甲基异苯并呋喃-1(3H)-酮及其衍生物合成新方法

报道了3-亚甲基异苯并呋喃-1(3H)-酮及其衍生物简易、高效的合成方法.其特点是原料易得且价格低廉、反应条件温和、收率高.该方法以2-甲基苯甲酸及其衍生物为原料,经过酯化、自由基溴代和三苯基膦发生亲核取代反应合成了2-[(溴三苯基正膦基)甲基]苯甲酸甲酯及其衍生物;随后发生Wittig反应、羧酸酯碱性条件下水解得到2-乙烯基苯甲酸及其衍生物;接着和碘(NBS)发生环合反应,生成3-碘(溴)甲基异苯并呋喃-1(3H)-酮及其衍生物;最后消除卤化氢得到目标化合物.     

新型2-硫代喹唑啉二酮类PARP-1抑制剂的合成及其生物活性

分别以苯胺(衍生物)与苯甲醛(衍生物)为起始原料,合成关键中间体5-(6-氟-4-氧代-2-硫-3,4-二氢-2H-喹唑啉基-1-甲基）苯甲酸（6a）、 2-氟-5-(6-氟-4-氧代-2-硫-3,4-二氢-2H-喹唑啉-1-基甲基)苯甲酸（6b）和2-氟-5-｛［4-氧代-2-硫-3,4-二氢吡啶并[2,3-d]嘧啶-1(2H)-基］甲基］｝苯甲酸（6c）;再经多步反应合成了14个含喹唑啉二酮骨架的PARP-1抑制剂(8a~8n),其结构经¹H NMR和MS(ESI)表征。体外活性测试结果显示：化合物1-{3-[4-(环戊烷羰基)-3-甲基哌嗪-1-羰基]-4-氟苄基}-6-氟-2-硫代-2,3-二氢-1H-喹唑啉-4-酮（8g）和1-{3-[4-(环己烷羰基)-3-甲基哌嗪-1-羰基]-4-氟苄基}-6-氟-2-硫代-2,3-二氢-1H-喹唑啉-4-酮（8h）对人乳腺癌细胞MDA-MB-436的抑制活性最强,IC₅₀分别为64.3 nmol·L^-1和86.4 nmol·L^-1,与阳性对照药奥拉帕尼的抑制活性处于同一数量级（IC₅₀=48.3 nmol·L^-1)。     

丙烯腈的化学Ⅱ.丙烯腈和取代4-氧代-2-硫代-四氢化噻唑

4-氧代-2-硫代-四氫化噻唑的芳香族醛類衍生物,和丙烯腈作用,在室温下同時在呈微鹼性的水溶液中,可以發生反應。依此我們製備了:5-苯亞甲基-3-(β-腈乙基)-4-氧代-2-硫代-四氫化噻唑,5-對甲氧基苯亞甲基-3-(β-腈乙基)-4-氧代-2-硫代-四氫化噻唑,5-呋喃亞甲基-3-(β-腈乙基)-4-氧代-2-硫代-四氫化噻唑以及5-對甲苯亞甲基-3-(β-腈乙基)-4-氧代-2-硫代-四氫化噻唑。     

(R)-2-{[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基亚硫酰基}- 1H-苯并咪唑的合成

以2,3-二甲基吡啶为起始原料, 经过11步反应, 不对称合成了质子泵抑制剂的关键中间体: (R)-2-{[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基亚硫酰基}-1H-苯并咪唑. 研究了用手性高效液相色谱拆分对映体、测定产品光学纯度的方法, 结果表明目标产品的ee值达到99%. 通过IR, UV, MS以及1H NMR分析对重要中间体和目标产品进行了结构鉴定.     

Synthesis and characterization of complexes of organotin(IV) with 2-thiazoline-2-thione

The reaction of 2-thiazoline-2-thione (TZDSH) with SnR₂Cl₂ (R=Ph 1, Me 2, Bu 3) in dry ethanol in the presence of sodium ethoxide leads to [SnR₂(C₃H₄NS₂)₂] (1, 2, and 3), respectively. Reaction between TZDSH and SnPh₂Cl₂ in dichloromethane and dry ethanol in an inert atmosphere produces [SnPh₂Cl₂(C₃H₅NS₂)₂] (4). The yields of the products were over 80%. These new complexes have been characterized by IR, UV-Vis, multinuclear (¹H, ¹³C, and ¹¹⁹Sn) NMR spectroscopy, and mass spectrometry, as well as elemental analysis.     

Crystal structures of two polymeric bis(triphenyltin) malonates

In an attempt to prepare potassium/sodium salts of malonato-triphenylstannate, two bis(triphenyltin) malonates were obtained instead, [(C₆H₅)₃Sn]₃[O₂CCH₂CO₂]_1.5 (1) and {[(C₆H₅)₃SnO₂CCH₂CO₂Sn(C₆H₅)₃]H₂O}CH₃CH₂OH (2). This provides an excellent example of structural diversity in triorganotin carboxylates. In both complexes, the dicarboxylate was connected to the triphenyltin groups forming a linear infinite polymeric chain. Both complexes have a trans-trigonal bipyramidal geometry with the three phenyl groups occupying the equatorial plane and two oxygens at axial positions. Both short and long tin–oxygen distances were observed in 1 and 2. In 1, all carboxylates functioned as bridging bidentate ligands, resulting in an infinite 3-D polymer network propagating along all three axes. In 2, Sn1 is bonded to a carboxylate and a water molecule (Sn1–O1 2.145(3)?Å, Sn1–O3 2.341(3)?Å, O1–Sn1–O3 173.97(12)°). Only one carboxylate acts as a bidentate ligand allowing the carbonyl group to be axially coordinated to the adjacent tin, Sn2. Also, Sn2 is covalently bonded to the other carboxylate group in the malonate ligand (Sn2–O4 2.163(3)?Å, Sn2–O5 2.353(3)?Å, O4–Sn2–O5 173.47(12)°). There is a water molecule included in the crystal lattice hydrogen bonded to the uncoordinated carbonyl in malonate.     

3D coordination polymers with vanadyl fragments and alkaline earth metal ions

The reactions of vanadyl sulfate VOSO₄·3H₂O with barium or strontium cyclopropane-1,1-dicarboxylate (MCpdc, M = Ba, Sr, H₂Cpdc = C₃H₄(COOH)₂) afforded the polymeric heterometallic complexes {[(H₂O)₈Ba₂(VO)₂(Cpdc)₄]·2H₂O}n (1) and {[(H₂O)₆Sr(VO)(Cpdc)₂]}n (2), respectively. These complexes differ in the binding mode of mononuclear vanadyl fragments with alkaline earth metal ions. Coordination polymers 1 and 2 were characterized by ESR spectroscopy.     

Tin(IV) and organotin(IV) derivatives of novel β-diketones: Part IV. Triorganotin(IV) complexes of fluorinated 4-acyl-5-pyrazolones. Crystal structure of (1-(4-trifluoromethylphenyl)-3-methyl-4-acetylpyrazolon-5-ato)triphenyltin(IV)

The synthesis of three 1-(4-trifluoromethylphenyl)-3-methyl-4-R¹(C=O)-5-pyrazolone proligands LH (L¹H; R¹=C₆H₅: L²H; R¹=CH₃: L³H; R¹=CF₃) and their interaction with R₃Sn(IV) acceptors (R=Me, Buⁿ, Ph) are reported. When R=Me or Buⁿ, aquo (4-acylpyrazolonate)SnR₃(H₂O) derivatives are obtained and the anionic donors 4-acylpyrazolonate (L⁻) act in the O–monodentate form. These triorganotin complexes are not stable in chlorohydrocarbon solvents and decompose to R₄Sn and bis(4-acyl-5-pyrazolonate)₂SnR₂. When R=Ph, stable (4-acyl-5-pyrazolonate)SnPh₃ derivatives, both in solution and in the solid state, are obtained. The crystal structure of (1-(4-trifluoromethylphenyl)-3-methyl-4-acetylpyrazolon-5-ato)triphenyltin(IV) shows a five-coordinate tin atom in a strongly distorted cis-bipyramidal trigonal environment (axial angle=161.2(2)°) with the acylpyrazolonate donor acting as an asymmetric O₂–bidentate species (Sn–O(1)=2.081(6) Å: Sn–O(2)=2.424(5) Å). Electronic effects are responsible for the different behavior shown by these trialkyl and triphenyl derivatives.     

Preparation and characterization of copper sulfide nanoparticles from symmetrical [(Bu)2NC(S)NC(O)C6H3(3,5-NO2)2]2Cu(II) and [(Bu)2NC(S)NC(O)C6H4(4-NO2)]2Cu(II) complexes by thermolysis

Trigonal copper sulfide nanoparticles were synthesized from symmetrical [(Bu)₂NC(S)NC(O)C₆H₃(3,5-NO₂)₂]₂Cu(II) and [(Bu)₂NC(S)NC(O)C₆H₄(4-NO₂)]₂Cu(II) complexes by thermolysis in the presence of surfactant oleylamine. The symmetrical copper complexes were synthesized by reaction of copper(II) acetate with N-(3,5-dinitrobenzoyl)-N′,N′-dibutylthiourea and N-(4-nitrobenzoyl)-N′,N′-dibutylthiourea. The symmetrical copper complexes were characterized by FT-IR spectroscopy, elemental analysis, and mass spectrometry (MS-APCI). The single-crystal X-ray structure of [(Bu)₂NC(S)NC(O)C₆H₄(4-NO₂)]₂Cu(II) has been determined from single-crystal X-ray diffraction data. These metal complexes have been used as single source precursors for the preparation of copper sulfide nanoparticles. The deposited copper sulfide nanoparticles were characterized by X-ray powder diffraction and transmission electron microscopy.     

Triaquatris(μ‐oxydiacetato)dipraseodymium(III) pentahydrate and hexaaquatris(μ‐oxydiacetato)dineodymium(III) oxydiacetic acid solvate dihydrate

Two new complexes of the Ln₂(oda)₃·nH₂O (oda =–O₂CCH₂OCH₂CO₂–) series are reported, i.e. {[Pr₂(C₄H₄O₅)₃(H₂O)₃]·5H₂O}_n and {[Nd₂(C₄H₄O₅)₃(H₂O)₆]·C₄H₆O₅·‐2H₂O}_n. The former is isostructural with the reported La analogue, while the latter is a new structural variety within the series. Each compound exhibits two independent nine‐coordinated Ln centres showing a variety of coordination geometries.     

Syntheses and Structures of trans-bis(Alkenylacetylide) Ruthenium Complexes

A series of ruthenium alkenylacetylide complexes trans-[Ru{C≡CC(=CH₂)R}Cl(dppe)₂] (R=Ph ( 1 a ), ^cC₄H₃S ( 1 b ), 4-MeS-C₆H₄ ( 1 c ), 3,3-dimethyl-2,3-dihydrobenzo[b]thiophene (DMBT) ( 1 d )) or trans-[Ru{C≡C-^cC₆H₉}Cl(dppe)₂] ( 1 e ) were allowed to react with the corresponding propargylic alcohol HC≡CC(Me)R(OH) (R=Ph ( A ), ^cC₄H₃S ( B ), 4-MeS-C₆H₄ ( C ), DMBT ( D ) or HC≡C-^cC₆H₁₀(OH) ( E ) in the presence of TlBF₄ and DBU to presumably give alkenylacetylide/allenylidene intermediates trans-[Ru{C≡CC(=CH₂)R}{C=C=C(Me)}(dppe)₂]PF₆ ([ 2 ]PF₆). These complexes were not isolated but deprotonated to give the isolable bis(alkenylacetylide) complexes trans-[Ru{C≡CC(=CH₂)R}₂(dppe)₂] (R=Ph ( 3 a ), ^cC₄H₃S ( 3 b ), 4-MeS-C₆H₄ ( 3 c ), DMBT ( 3 d )) and trans-[Ru{C≡C-^cC₆H₉}₂(dppe)₂] ( 3 e ). Analogous reactions of trans-[Ru(CH₃)₂(dmpe)₂], featuring the more electron-donating 1,2-bis(dimethylphosphino)ethane (dmpe) ancillary ligands, with the propargylic alcohols A or C and NH₄PF₆ in methanol allowed isolation of the intermediate mixed alkenylacetylide/allenylidene complexes trans-[Ru{C≡CC(=CH₂)R}{C=C=C(Me)}(dmpe)₂]PF₆ (R=Ph ([ 4 a ]PF₆), 4-MeS-C₆H₄ ([ 4 c ]PF₆). Deprotonation of [ 4 a ]PF₆ or [ 4 c ]PF₆ gave the symmetric bis(alkenylacetylide) complexes trans-[Ru{C≡CC(=CH₂)R}₂(dmpe)₂] (R=Ph ( 5 a ), 4-MeS-C₆H₄ ( 5 c )), the first of their kind containing the dmpe ancillary ligand sphere. Attempts to isolate bis(allenylidene) complexes [Ru{C=C=C(Me)R}₂(PP)₂]²⁺ (PP=dppe, dmpe) from treatment of the bis(alkenylacetylide) species 3 or 5 with HBF₄ ⋅ Et₂O were ultimately unsuccessful.     

Synthesis and characterization of dimeric organotin compounds {[(ArCH2)2 Sn(2‐quin)]2O}2 and crystal structure of {[(2‐ClC6 H4CH2)2Sn(2‐quin)]2O}2

Ten new dimeric organotin compounds {[(ArCH₂)₂ Sn(2‐quin)]₂O}₂ (Ar = Ph 1 , 2‐ClC₆H₄ 2 , 3‐ClC₆H₄ 3 , 4‐ClC₆H₄ 4 , 2‐FC₆H₄ 5 , 3‐FC₆H₄ 6 , 4‐FC₆H₄ 7 , 4‐BrC₆H₄ 8 , 4‐CNC₆H₄ 9 , 2,4‐Cl₂C₆H₃ 10 ) have been synthesized by dealkylation reactions of 2‐quinH with [(ArCH₂)₃Sn]₂O, and their structures have been characterized by elemental analysis, IR and NMR (¹}H, ¹³C, ¹¹⁹Sn) spectroscopies. The structures of {[(2‐ClC₆H₄CH₂)₂Sn(2‐quin)]₂O}₂ 2 have been determined by X‐ray diffraction. Studies show that compound 2 has a tetranuclear, centrosymmetric dimeric structure, with the endo‐cyclic tin atom five‐coordinated and the exo‐cyclic tin atom six coordinated. Studies also show that the nitrogen atoms of the 2‐quin ligand are coordinating to the tin atom for all the ten compounds. © 2006 Wiley Periodicals, Inc. Heteroatom Chem 17:152–159, 2006; Published online in Wiley InterScience ( www.interscience.wiley.com ). DOI 10.1002/hc.20194     

一系列由柔性N,N'-双(3-吡啶甲基)胺构筑的螺旋配合物的合成、结构和性质

合成和表征了5个螺旋配位聚合物{[Cu(Hbpma)(H₂O)₄]₂(SO₄)₃·3.5H₂O}_n (1)、{[Ni(Hbpma)(H₂O)₄]₄(SO₄)₆·10.75H₂O}_n (2)、{[Mn(Hbpma)(H₂O)₄](SO₄)_1.5·3H₂O}_n (3)、{[Zn(Hbpma)(H₂O)₄]₄(SO₄)₆·4H₂O·4CH₃OH}n (4)和{[Cu(Hbpma)2(H₂O)₂](SO₄)₂·9H₂O}_n (5), 其中bpma代表N,N'-双(3-吡啶甲基)胺。晶体结构分析表明配合物1~4为一维链状结构, 配合物5为二维层状结构, 其中金属离子由质子化的bpma配体桥连。值得注意的是, 采取反-反式构象的柔性bpma配体使得配合物1和2为假螺旋链结构, 配合物3和4为螺旋链结构, 配合物5为螺旋层结构。同时研究了配合物的磁性和热稳定性。     

The reactions of non-gem-hexanedioxytetrachlorocyclotriphosphazene with 2-(2-hydroxyethyl)thiophene,benzyl alcohol and 1,1,3,3-tetramethylguanidine. Spectroscopic studies of the derived products

Abstract

Reactions of non-gem-hexanedioxytetrachlorocyclotriphosphazene (1) with monofunctional nucleophilic reagents, 2-(2-hydroxyethyl)thiophene (2), benzyl alcohol (3) and 1,1,3,3-tetramethylguanidine (4) were investigated. The reactions, using an excess of NaH, in THF solutions, under refluxing conditions and with 1:2?mole ratios allow the synthesis of the following novel cyclotriphosphazene derivatives: 2,4-dichloro-2,4-(hexane-1,6-dioxy)-6,6-[2-(2-ethoxy)hiophene]-cyclotriphosphazatriene, N₃P₃Cl₂[O(CH₂)₆O-(C₆H₈OS)₂] (5); 2,4-(hexane-1,6-dioxy)-2,4,6,6-[2-(2-ethoxy) thiophene]-cyclotriphosphazatriene, N₃P₃[O(CH₂)₆O-(C₆H₈OS)₄] (6); 2,4-dichloro-2,4-(hexane-1,6-dioxy)-6,6-(methoxybenzene)-cyclotriphosphazatriene, N₃P₃Cl₂[O(CH₂)₆O-(C₆H₅CH₂O)₂] (7); 2,4-(hexane-1,6-dioxy)-2,4,6,6-(methoxybenzene)-cyclotriphosphazatriene, N₃P₃[O(CH₂)₆O-(C₆H₅CH₂O)₄] (8); and 2,4-dichloro-2,4-(hexane-1,6-dioxy)-6,6-(1,1,3,3-tetramethyguanidine)-cyclotriphosphazatriene, N₃P₃Cl₂[O(CH₂)₆O-HN-CN₂(CH₃)₄] (9). The structures of the synthesized compounds (5–9) have been characterized by elemental analysis, TLC-MS, ¹H, ¹³C and ³¹P {+¹H} and {?¹H} NMR spectral data.